Description

The Morcher 67B Aniridia IOL is a specialized intraocular lens designed to address significant iris defects, such as those associated with aniridia. Crafted by Morcher, this innovative device serves a dual purpose: providing light occlusion and visual rehabilitation for patients with large iris deficiencies.

Key Features

• Size and Design: The implant measures 12.5 mm and includes a 3-mm optic, making it suitable for sulcus placement or scleral suturing. This design allows it to function effectively as both an artificial iris and a lens.
• Optic Variability: The optics are available in various diameters, offering flexibility to meet specific patient needs.

Intended Use

The primary function of this implant is to replace missing or damaged iris tissue, thereby restoring vision and improving quality of life for individuals with significant iris defects. Its black color may be more noticeable in patients with lighter-colored irises, which could affect cosmetic outcomes due to the limited color options.

Regulatory Information

It is important to note that the Morcher 67B Aniridia IOL is not FDA approved. In the United States, it is accessible only through clinical trials or compassionate use exemptions, underscoring its specialized application and the need for professional consultation.

This product represents a significant advancement in ocular prosthetics, offering a tailored solution for those with specific visual and cosmetic needs related to iris defects.